Relapse After Allogeneic Hematopoietic Cell Therapy

Relapse of disease remains a major cause of mortality following allogeneic hematopoietic cell therapy (HCT). Over the past decade there has been a tremendous increase in our understanding of the biology underlying the graft-versus-tumor/leukemia (GVT) effect. However, there are several other factors...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: van den Brink, Marcel R.M., Porter, David L., Giralt, Sergio, Lu, Sydney X., Jenq, Robert R., Hanash, Alan, Bishop, Michael R.
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3637945/
https://ncbi.nlm.nih.gov/pubmed/19857588
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2009.10.023
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars